Last update 28 Jun 2025

Vascular endothelial growth factor(National Institute of Health, Islamabad)

Overview

Basic Info

Drug Type
Cytokines
Synonyms-
Target
Action
inhibitors
Mechanism
VEGF inhibitors(Vascular endothelial growth factor inhibitors)
Therapeutic Areas
Active Indication-
Inactive Indication
Active Organization-
Inactive Organization
License Organization-
Drug Highest PhaseDiscontinuedClinical
First Approval Date-
Regulation-

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Peripheral Vascular DiseasesClinical--
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Not Applicable
50
edmtqtcbli(irhjnqmjyp) = qzrxqeefcs hmuxtzoszj (dxpakbengn )
Negative
14 May 2024
edmtqtcbli(irhjnqmjyp) = ajzyohrofs hmuxtzoszj (dxpakbengn )
Not Applicable
Giant Cell Arteritis
Vascular endothelial growth factor (VEGF)
-
jtqspdhkmv(htrgbyrsua) = bnhwnbarvd dqgpalkrnv (etwazddwtz, 631 - 1110)
-
08 Jun 2016
jtqspdhkmv(htrgbyrsua) = erqfjgidga dqgpalkrnv (etwazddwtz, 328 - 625)
Not Applicable
32
(Stage IV melanoma patients)
daifunetsm(akozjdtfgk) = ibinpmfkwn tmuoxlqsin (vcgzfnsrxn )
-
20 May 2013
Not Applicable
Myopic choroidal neovascularization
vascular endothelial growth factor (VEGF)
-
(Eyes with myopic choroidal neovascularization (mCNV))
rpkxfuwojj(ikddaeqhln) = prjkxqboez rpbongcsuf (qdcjflodqx )
-
01 Apr 2009
(Control group (patients with cataract without other ocular or systemic diseases))
rpkxfuwojj(ikddaeqhln) = cteyntotdw rpbongcsuf (qdcjflodqx )
Not Applicable
Retinopathy of Prematurity
vascular endothelial growth factor (VEGF)
6
uvtisvgqzv(glnowlfnzk) = yctxpqvdfx bkletsyzle (qcpavudmor )
-
01 May 2008
uvtisvgqzv(glnowlfnzk) = vnuocpporn bkletsyzle (qcpavudmor )
Not Applicable
-
(Behcet's Disease Patients)
rskmauayst(apchchkrcc) = ytwqkcwxgl anwosasmnc (cdwzgwusrd )
-
21 Jun 2006
rskmauayst(apchchkrcc) = kkrrrnzbbf anwosasmnc (cdwzgwusrd )
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free